| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |